Maternal PFOS exposure in mice induces hepatic lipid accumulation and inflammation in adult female offspring: Involvement of microbiome-gut-liver axis and autophagy

J Hazard Mater. 2024 May 15:470:134177. doi: 10.1016/j.jhazmat.2024.134177. Epub 2024 Mar 30.

Abstract

Perfluorooctane sulfonates (PFOS) are the persistent organic pollutants. In the present study, 0, 0.3, or 3-mg/kg PFOS were administered to pregnant mice from GD 11 to GD 18. The histopathology of liver and intestine, serum and hepatic lipid levels, lipid metabolism related genes, and gut microbiota were examined in adult female offspring. The results suggested that maternal PFOS exposure increased serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), and induced F4/80+ macrophage infiltration in adult female offspring, in addition to the elevation of TNF-α and IL-1β mRNA levels in low-dose and high-dose groups, respectively. Furthermore, maternal exposure to PFOS increased serum triglyceride (TG) and hepatic total cholesterol (TC) levels, which was associated with the alteration of the process of fatty acid transport and β-oxidation, TG synthesis and transport, cholesterol synthesis and excretion in the liver. The AMPK/mTOR/autophagy signaling was also inhibited in the liver of adult female offspring. Moreover, changes in gut microbiota were also related to lipid metabolism, especially for the Desulfovibrio, Ligilactobacillus, Enterorhabdus, HT002 and Peptococcaceae_unclassified. Additionally, maternal exposure to PFOS decreased mRNA expressions of the tight junction protein and AB+ goblet cells in the colon, while increasing the overproduction of lipopolysaccharides (LPS) and F4/80+ macrophage infiltration. Collectively, maternal PFOS exposure induced liver lipid accumulation and inflammation, which strongly correlated with the disruption of the gut-liver axis and autophagy in adult female offspring, highlighting the persistent adverse effects in offspring exposed to PFOS.

Keywords: Gut-liver axis; Hepatic autophagy; Lipid accumulation; Maternal exposure; Perfluorooctane sulfonates.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkanesulfonic Acids* / toxicity
  • Animals
  • Autophagy* / drug effects
  • Female
  • Fluorocarbons* / toxicity
  • Gastrointestinal Microbiome* / drug effects
  • Inflammation / chemically induced
  • Lipid Metabolism* / drug effects
  • Liver* / drug effects
  • Liver* / metabolism
  • Male
  • Maternal Exposure* / adverse effects
  • Mice
  • Pregnancy
  • Prenatal Exposure Delayed Effects*

Substances

  • Fluorocarbons
  • perfluorooctane sulfonic acid
  • Alkanesulfonic Acids